As COVID-19 vaccines progress, science and policy questions become more urgent
GSK-Sanofi deal underscores importance of tested technologies, manufacturing capacity in search for vaccine
The collaboration announced Tuesday between Sanofi and GlaxoSmithKline highlights the importance of bringing tested technologies and large-scale manufacturing capacity to the search for safe, effective COVID-19 vaccines.
The partnership, which combines the strengths of two of the largest vaccine manufacturers, also provides an opportunity to consider some of the practical aspects of moving from the lab to mass manufacturing. ...